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Abstract 
 
Objective: The aim of this study was to determine the role of magnetic 
resonance imaging (MRI), auditory evoked potentials (AEP) and vestibular 
evoked myogenic potentials (VEMP) in the evaluation of brainstem involvement 
in multiple sclerosis (MS). 
Patients and methods: Altogether 32 patients with the diagnosis of MS 
participated in the study. The following data was collected from all patients: age, 
gender, Expanded Disability Status Scale (EDSS) score, brainstem functional 
system score (BSFS) (part of the EDSS evaluating brainstem symptomatology), 
and involvement of the brainstem on the brain MRI. AEP and ocular VEMP 
(oVEMP) and cervical VEMP (cVEMP) were studied in all patients. 
Results: BSFS, MRI, AEP, oVEMP and cVEMP involvement of the brainstem was 
evident in 9 (28.1%), 14 (43.8%), 7 (21.9%), 12 (37.5%) and 10 (31,0%) 
patients, respectively. None of the test used showed statistically significant 
advantage in the detection of brainstem lesions. When combining oVEMP and 
cVEMP 18 (56.3%) patients showed brainstem involvement.  This combination 
showed brainstem involvement in greater percentage than BSFS or AEP, with 
statistical significance (p=0.035 and p=0.007, respectively). 
Conclusion: VEMP is a reliable method in detection of brainstem involvement in 
MS. It is comparable with MRI, but superior to clinical examination or AEP. 
 
Key words: Auditory evoked potentials, vestibular evoked myogenic potentials, 
brainstem, multiple sclerosis 
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Introduction 
 
Multiple sclerosis (MS) is a chronic idiopathic demyelinating illness of the central 
nervous system and it is the leading cause of disability in young adults.  
It is estimated that around 65% of MS patients had one or more brainstem or 
cerebellar manifestations in the course of the disease. (1) The presence of 
infratentorial lesions has been associated with worse Expanded Disability Status 
Scale (EDSS) score at follow-up and is one of the major predictive factors for 
future disability. (2, 3) As well, several studies have shown that infratentorial 
lesions are related to long-term prognosis for patients with clinically isolated 
syndrome and thus may help to identify patients at high risk for earlier 
occurrence of clinically relevant disability. (4, 5) 
Although there is relatively good correlation between brainstem impairment and 
T2 lesion burden, the association between clinical findings and radiological 
extent of involvement generally is poor (the so called clinico-radiological 
paradox). (6, 7)  
Evoked potentials are reliable procedures to predict disability in MS patients. 
Index of global EP alteration (EP score) which combines alterations in visual 
evoked potentials, AEP, motor and somatosensory evoked potentials showed 
significant correlation with EDSS score at the time of neurophysiological study 
and at 1, 3 and 5 years of follow-up. (8) On the other hand, AEP alone are 
insufficient in detecting subclinical lesions of the brainstem. (9) However, newer 
brainstem evoked potentials like ocular and cervical vestibular evoked myogenic 
potentials (oVEMP and cVEMP) have shown promise in detecting brainstem 
involvement in MS.(10) 
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The aim of the present study was to determine the role of MRI, AEP and VEMP in 
the evaluation of brainstem involvement in MS.  
 
 
Patient and Methods 
 
Patients: Patients with the diagnosis of relapsing-remitting MS according to the 
revised McDonald’s criteria were prospectively included in the study. (11) The 
following data was collected from all patients: age, gender, Expanded Disability 
Status Scale (EDSS) score, brainstem functional system score (BSFS) (part of the 
EDSS evaluating brainstem symptomatology), and involvement of the brainstem 
on the brain MRI. All participants were informed about the details of the 
experiment and they all signed informed consent forms. Study was approved by 
the Ethical committee of the University Hospital Centre Zagreb. 
 
Auditory evoked potentials: During the experiment participants sat or lay in a 
relaxed position in slightly darkened room. Their eyes were closed in order to 
avoid ocular artifacts. Activity was recorded with four surface disk electrodes. 
Active electrodes were situated on the mastoids on both sides and referred to 
the vertex electrode Cz. Frontal electrode Fz was used as ground electrode.  
A pair of headphones delivered the stimuli. The stimulation rate was 10 Hz and 
stimuli were acoustic clicks of 0.1 ms duration. At the beginning of the 
experiment the perceptive threshold for each participant for each ear was 
assessed. During the experiment, the intensity of stimulation delivered to the 
tested ear was 70 dB higher than the perceptive threshold. In the same time the 
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white noise with the intensity 30 dB lower than the intensity delivered to the 
tested ear was delivered to the contralateral ear in order to reduce the effect of 
the bone conductivity. Each series consisted of 1000 stimuli and was repeated 
twice for each ear in order to provide reproducibility. Recordings were 
performed using Medelec Synergy, Oxford Instruments, UK. Automated analysis 
according to the normative values was performed with the same system. 
The results of AEP were regarded either as pathological or normal according to 
the normative values for the laboratory.  
Vestibular evoked myogenic potentials: During the experiment participants 
sat in comfortable chair. Patients were instructed to slightly move their head 
away from the back of the chair and push it forward in order to activate 
sternocleidomastoid muscle. The contraction of muscle was maintained due to 
the cooperation of patients in maintaining the same position during the test.  
Participants were also instructed to direct their gaze to the ceiling in order to 
activate ocular muscles.  The evoked response from the SCM was recorded from 
the active surface electrode placed on the belly of the SCM of the stimulated side 
and referred to the surface electrode placed on the tendon of the same SCM. The 
evoked response from the OM was recorded from two surface electrodes 
situated 2 cm below the contralateral eye. Active electrode was situated closer to 
the eye and referred to the reference 1 cm below. The stimuli were delivered by 
a pair of headphones in series of 50 trails to one ear at a time and repeated two 
times for each ear in order to provide reproducibility. The presented stimuli 
were acoustic clicks of 1 ms duration at the intensity of 130 dB SPL and the 
stimulation frequency of 1 Hz. Recording were performed using a Brain Products 
Brain Vision Recorded and the analysis of the recorded data was performed 
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using a Brain Products Brain Vision Analyzer. Signals were filtered with 
bandpass filter from 5 Hz to 1000 Hz. For the purpose of the analysis signals 
were divided in segments of 120 ms duration (20 ms before the stimulus and 
100 ms after the stimulus) and averaged for each set of 50 trials. From the 
averaged responses from the two sets, the grand average was computed and 
used for further analysis. We used baseline normalized values of the SCM 
amplitude data instead of the absolute value of amplitude, because absolute 
amplitude of the evoked response depends on the amplitude of the muscle 
activity (muscle contraction) and is not reliable measure. The baseline 
normalized value of amplitude is calculated by dividing the absolute peak to 
peak amplitude (P13-N23) with mean value of rectified activity of muscle in the 
period prior the stimulus. 
The results of oVEMP and cVEMP were regarded either as pathological or normal 
according to the normative values for the laboratory. 
Statistical analysis: Statistic analysis was performed using IBM SPSS 19.0 
(Chicago, IL). We used the McNemar's test, which evaluates changes in related or 
paired binomial attributes, whether changes in one direction is significantly 
greater than that in the opposite direction. Phi correlation was performed for 
MRI, AEP, VEMP and clinical brainstem involvement. P values less than 0.05 
were considered significant. 
 
Results 
 
Altogether 32 patients participated in the study, 19 females and 13 males, aged 
from 21 to 49 years (median 29 years). Median EDSS was 2 (range from 0 to 3.5). 
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Clinical involvement of the brainstem was evident in 9 (28.1%) patients, 
meaning that BSFS was greater or equal to 1. Brainstem lesions were evident on 
MRI in 14 (43.8%) patients. 
In only 7 (21.9%) patients AEP showed brainstem involvement. In contrast 
oVEMP showed brainstem involvement in 12 (37.5%) and cVEMP in 10 (31.0%) 
patients. When combining oVEMP and cVEMP 18 (56.3%) patients had signs of 
brainstem involvement. 
Although brain MRI showed brainstem involvement in the greatest percentage of 
patients, none of the test used showed statistically significant advantage in the 
detection of brainstem lesions (BSFS vs AEP p=0.791; BSFS vs MRI p=0.227; 
BSFS vs cVEMP p=1, BSFS vs oVEMP p= 0.549, AEP vs MRI p=0.092; AEP vs 
cVEMP p=0.549, AEP vs oVEMP p= 0.302; MRI vs cVEMP p=0.344; MRI vs oVEMP 
0.815). Graphical presentation of these results is presented in Figure 1. 
However, when oVEMP and cVEMP results are combined, the VEMP results 
showed brainstem involvement in greater percentage than BSFS or AEP, with 
statistical significance (p=0.035 and p=0.007, respectively) (Table 1). Graphical 
presentation of these results is presented in Figure 2. 
There was no correlation between all studies variables (BSFS and AEP: Phi -
0.163, p=0.357; BSFS and MRI: Phi 0.289, p=0.102; BSFS and VEMP: Phi 0.131, 
p=0.457, MRI and AEP: Phi 0.143, p=0.419; VEMP and AEP: Phi 0.162, p=0.360, 
MRI and VEMP: Phi 0.016, p=0.928). 
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Discussion 
 
Results of this study showed that combination of oVEMP and cVEMP is superior 
in detecting brainstem involvement than clinical examination and AEP. VEMP 
detects brainstem involvement in greater percentage than MRI, however this 
was not statistically significant.  
Bearing in mind the poor correlation between clinical symptoms and MRI 
findings there is a need for ancillary tools in the evaluation of brainstem 
pathology in MS. (6)  
Compared to healthy individuals, patients with relapsing-remitting MS have 
higher values for latencies of waves III and V and interpeaks I-III and I-V of AEP. 
(12) The combined application of AEP, the auditory middle latency response, and 
slow cortical potentials promotes better detection of silent MS loci than either of 
these EP alone. (13) Although AEP may be normal in 30 - 50% of MS patients 
with symptoms or signs of brainstem involvement, (9, 14) one study on a relatively 
small number of patients showed that AEP was able to localize lesions along the 
auditory pathways at a rate that was almost similar to that of MR imaging. (15) 
Our study showed relatively small percentage of pathological AEP in MS patients 
compared to MRI and VEMP.  
Several studies have already shown that cVEMP is a useful diagnostic method in 
an evaluation of clinically silent lesions in patients with MS. (16, 17) In patients 
with MS, cVEMPs are abnormal in up to 50% of patients, and similar results were 
obtained in our study as well. (17-22) However, when cVEMP and oVEMP are 
combined up to 80% of patients have pathological finding. (23) Although there 
was no statistical significance between brainstem clinical findings with 
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brainstem MRI and cVEMP findings in this study, statistically significant 
difference was found between brainstem clinical findings and oVEMP (p=0.02) 
(with no statistical significance between brainstem MRI and oVEMP). (23)  
The main shortcoming of the present study is relatively small number of 
patients. However the results have clearly shown that VEMP is a reliable method 
in detection of brainstem involvement in MS. It is comparable with MRI, but 
superior to clinical examination or AEP. Although VEMP detects brainstem 
involvement in greater percentage then the MRI, this difference did not reached 
statistical significance. Further studies with larger number of patients and 
follow-up are needed to establish the definite role of VEMP in the diagnosis and 
monitoring of MS patients.   
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Tables 
 
Table 1. Clinical, MRI and evoked potentials ability to detect brainstem 
involvement in the studied cohort. 
Studied parameter p value 
BSFS vs AEP 0.791 
BSFS vs VEMP 0.035 
BSFS vs MRI 0.227 
AEP vs VEMP 0.007 
AEP vs MRI 0.092 
VEMP vs MRI 0.454 
BSFS brainstem functional system score (part of the EDSS) showing clinical 
involvement of the brainstem; AEP audiotory evoked potentials, VEMP vestibular 
evoked myogenic potentials, MRI magnetic resonance imaging 
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Figures 
 
Figure 1. Clinical, MRI and evoked potentials findings showing brainstem 
involvement in the studied cohort. 
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Figure 2. Clinical, MRI and evoked potentials findings showing brainstem 
involvement in the studied cohort, when oVEMP and cVEMP results are 
combined. 
 
 
 
 
 
 
